Jefferies Financial Group Inc. Pacira Bio Sciences, Inc. Transaction History

Jefferies Financial Group Inc.

$10.7 Billion
Q1 2025

A detailed history of Jefferies Financial Group Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 174,292 shares of PCRX stock, worth $4.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

174,292

Previous 98,770 76.46%

Holding current value

$4.6 Million

Previous $1.86 Million 132.85%

% of portfolio

0.04%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$18.33 - $27.25 $1.38 Million - $2.06 Million	75,522 Added 76.46%	174,292 $4.33 Million
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $1.07 Million - $1.43 Million	70,220 Added 245.95%	98,770 $1.86 Million
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $252,134 - $613,313	-21,550 Reduced 43.01%	28,550 $429,000
Q2 2024 Aug 13, 2024	SELL	$25.5 - $31.51 $66,835 - $82,587	-2,621 Reduced 4.97%	50,100 $1.43 Million
Q1 2024 May 13, 2024	SELL	$27.7 - $35.48 $294,728 - $377,507	-10,640 Reduced 16.79%	52,721 $1.54 Million
Q4 2023 Feb 13, 2024	BUY	$26.32 - $34.31 $755,357 - $984,662	28,699 Added 82.8%	63,361 $2.14 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $624,368 - $815,871	20,351 Added 142.21%	34,662 $1.06 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $498,997 - $656,212	-13,815 Reduced 49.12%	14,311 $573,000
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $35,352 - $43,163	-995 Reduced 3.42%	28,126 $1.15 Million
Q4 2022 Sep 21, 2023	BUY	$38.19 - $57.45 $510,371 - $767,761	13,364 Added 93.38%	27,675 $1.07 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $1.11 Million - $1.67 Million	29,121 New	29,121 $1.12 Million

Others Institutions Holding PCRX

# of Institutions

254

Shares Held

51.1M

Call Options Held

157K

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.21B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Account

Jefferies Financial Group Inc. Pacira Bio Sciences, Inc. Transaction History